Crossmark

Ameliorative role of rolipram, PDE-4 inhibitor, against sodium arsenite–induced vascular dementia in rats

Published Online: 2021-07-05

Published Print: 2021-11

Authors

Virk, Divjot

Kumar, Amit

Jaggi, Amteshwar Singh

Singh, Nirmal https://orcid.org/0000-0001-6143-5284
License Information

Text and Data Mining valid from 2021-07-05

Version of Record valid from 2021-07-05
More Information

Article History

Received: 18 December 2020

Accepted: 24 June 2021

First Online: 5 July 2021

Declarations

:

: The study was duly approved by the institutional animal ethical committee and the care of the rats was carried out as per the guidelines of Committee for the Purpose of Control and Supervision of Experiments on Animals, Ministry of Environment and Forests, Government of India. The experimental protocol was approved by the institutional animal ethics committee via approval no. 107/99/CPCSEA/2014-02.

: Not applicable

: All authors have read and given their consent to publish this manuscript.

: The authors declare no competing interests.

Document is current